123 related articles for article (PubMed ID: 10742835)
1. Optimization of tumor radiotherapy. Part VI: Modification of tumor glucose metabolism for increasing the bioavailability of 2-deoxy-D-glucose (2-DG) in a murine tumor model.
Sharma RK; Singh S; Degaonkar M; Raghunathan P; Maitra A; Jain V
Strahlenther Onkol; 2000 Mar; 176(3):135-43. PubMed ID: 10742835
[TBL] [Abstract][Full Text] [Related]
2. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
Dwarakanath BS; Adhikari JS; Jain V
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapeutic response of Ehrlich ascites tumor cells perfused in agarose gel threads and implanted in mice. A 31P MR spectroscopy study.
Sharma RK; Jain V
Strahlenther Onkol; 2001 Apr; 177(4):212-9. PubMed ID: 11370557
[TBL] [Abstract][Full Text] [Related]
4. Tackling radioresistance of hypoxic cells by metabolic modulation of bioenergetics--a 31P MRS study on perfused Ehrlich ascites tumor cells.
Sharma RK; Jain V
Indian J Physiol Pharmacol; 2002 Jan; 46(1):51-60. PubMed ID: 12024957
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamide.
Varshney R; Gupta S; Dwarakanath BS
Technol Cancer Res Treat; 2004 Dec; 3(6):659-63. PubMed ID: 15560724
[TBL] [Abstract][Full Text] [Related]
6. In vivo NMR spectroscopic studies on the bioenergetic changes induced by metabolic modulators in Ehrlich ascites tumour cells.
Sharma RK; Hanssum H; Jain V
Indian J Biochem Biophys; 1996 Apr; 33(2):122-30. PubMed ID: 8754623
[TBL] [Abstract][Full Text] [Related]
7. Experimental evaluation of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG) as a possible adjuvant to radiotherapy of tumors: I. Kinetics of growth and survival of Ehrlich ascites tumor cells (EATC) in vitro and of growth of solid tumors after 2-DG and X-irradiation.
Purohit SC; Pohlit W
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):495-9. PubMed ID: 7107374
[No Abstract] [Full Text] [Related]
8. The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.
Gupta S; Mathur R; Dwarakanath BS
Cancer Biol Ther; 2005 Jan; 4(1):87-94. PubMed ID: 15711125
[TBL] [Abstract][Full Text] [Related]
9. Effects of 2-deoxy-D-glucose on the photosensitisation-induced bioenergetic changes in Saccharomyces cerevisiae as observed by in vivo NMR spectroscopy.
Sharma RK; Jain V
Indian J Biochem Biophys; 1994 Feb; 31(1):36-42. PubMed ID: 8076971
[TBL] [Abstract][Full Text] [Related]
10. Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice.
Singh S; Pandey S; Bhatt AN; Chaudhary R; Bhuria V; Kalra N; Soni R; Roy BG; Saluja D; Dwarakanath BS
PLoS One; 2015; 10(7):e0132089. PubMed ID: 26135741
[TBL] [Abstract][Full Text] [Related]
11. Experimental evidence on possibility to radiosensitize aggressive tumors by porphyrins.
Luksiene Z
Medicina (Kaunas); 2004; 40(9):868-74. PubMed ID: 15456974
[TBL] [Abstract][Full Text] [Related]
12. Changes in energy metabolism following roentgen irradiation of in vivo growing Ehrlich ascites tumour cells studied by 31P magnetic resonance spectroscopy.
Skog S; Nordell B; Ericsson A; Tribukait B; Nishida T
Acta Radiol Oncol; 1986; 25(1):63-9. PubMed ID: 3010654
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of hematoporphyrin derivative uptake in vitro and in vivo by tumor cells in the presence of lanthanum.
Crone-Escanye MC; Anghileri LJ; Robert J
Tumori; 1985 Feb; 71(1):39-43. PubMed ID: 3157250
[TBL] [Abstract][Full Text] [Related]
14. Optimization of tumour radiotherapy: Part V--Radiosensitization by 2-deoxy-D-glucose and DNA ligand Hoechst-33342 in a murine tumour.
Dwarakanath BS; Singh S; Jain V
Indian J Exp Biol; 1999 Sep; 37(9):865-70. PubMed ID: 10687280
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models.
Ohira H; Kubota K; Ohuchi N; Harada Y; Fukuda H; Satomi S
J Nucl Med; 2000 Sep; 41(9):1561-8. PubMed ID: 10994739
[TBL] [Abstract][Full Text] [Related]
16. The interaction of hematoporphyrin derivative, light, and ionizing radiation in a rat glioma model.
Kostron H; Swartz MR; Miller DC; Martuza RL
Cancer; 1986 Mar; 57(5):964-70. PubMed ID: 3943032
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
[TBL] [Abstract][Full Text] [Related]
18. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
19. Tumor response to ionizing radiation and combined 2-deoxy-D-glucose application in EATC tumor bearing mice: monitoring of tumor size and microscopic observations.
Latz D; Thonke A; Jüling-Pohlit L; Pohlit W
Strahlenther Onkol; 1993 Jul; 169(7):405-11. PubMed ID: 8342113
[TBL] [Abstract][Full Text] [Related]
20. A comparison of efficacy of photoradiation therapy and other conventional treatment modalities on experimental MS-2 sarcoma.
Pezzoni G; Savi G; Melloni E; Marchesini R; Fava G; Locati L; Zunino F
Cancer Lett; 1984 Dec; 25(2):209-16. PubMed ID: 6239681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
